Questioning the Legality of Regenerative Medicines – A Bioethical Conundrum

Abstract

The growth of regenerative medicine (RM) has become a famous area in today’s opinion. It is used and guided by patients, healthcare practitioners, and governments to reduce healthcare’s growing medical and financial challenges. It started in the twentieth century when the study of regeneration and transplantation gained popularity. Innovation in RM. is an area of interest for scientists, companies and nations aiming to solve healthcare challenges. This field is also challenged with questions regarding whether the use of specific technologies and methods should be considered within the scope of RM. While developing project-specific definitions and boundaries to frame research and analysis is common, the technical and legal nuances should also be considered. There is no ‘universally agreed’ definition of RM due to its diversified application and interdisciplinary nature. RM integrates expertise from disciplines such as stem cell biology, transplantation, genetics, molecular biology, and tissue engineering. Hence, the credibility of these medical procedures is so ambiguous and complex that it’s essential to enact a legal framework for regulating the same with transparency and ease. In the emerging human-engineering era, there are loads of biomedical potentials and bioethical risks that need to be addressed among the medical fraternity to formulate a law governing the RM. Therefore, my research is primarily proposed to address the legal and ethical challenges as an issue of concern that must be regulated to establish checks and balances on these new developing medical sciences and in solving bioethical problems.